Financials
- Market Capitalization 1.8 B
- Employee 264
- Founded 2003
- CEO Kenneth Galbraith
- Website www.zymeworks.com
- Headquarter Delaware, United States
- FIGI BBG019XSYC89
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-24.38
売上高対価格比率
18.74
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2059 | ZBIO Zenas BioPharma, Inc. - Common Stock | 28.78 USD | +3.23% | +5.19% | +53.41% | +8.77% | 1.82 B USD | ||
| 2060 | STOK Stoke Therapeutics, Inc. - Common Stock | 29.13 USD | -1.12% | -11.32% | -3.96% | +146.24% | 1.81 B USD | ||
| 2072 | AAPG Ascentage Pharma Group International - American Depository Shar | 19.24 USD | -1.94% | +4.96% | +13.11% | -23.04% | 1.80 B USD | ||
| 2084 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | +1.21% | -9.97% | +2.14% | -36.86% | 1.77 B USD |